Observatoire des droits humains (anglais seulement)

Appetite drug shows promise in treating obesity

(Version anglaise seulement)

par John Blundell, Professor of Psychobiology, University of Leeds

A recently published clinical trial of the anti-obesity drug, semaglutide, has produced a degree of weight loss which has led some to dub the medication a “game changer” in the treatment of obesity.

The trial looked at 1,961 adults who were overweight or obese. Approximately 75% of participants were female. Participants were given a weekly injection of semaglutide, a drug normally used to control blood…

Lire l'article complet